Botanical species · safety record

Fabiana imbricata

The EFSA Compendium of Botanicals holds 12 constituent measurements for Fabiana imbricata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fabiana imbricata Ruiz & Pav.

12Constituent measurements
0Safety records
5Cited sources
7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Fabiana imbricata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Tincture of yellow leaf sheet
  • Young leafy twigs
  • Young leafy twigs/shoots

What the records describe

Constituents measured

  • Scopoletin7
  • 4-hydroxyacetophenone2
  • Erythroglaucin1
  • Fabianine1
  • Physcion1

Plant parts

  • Aerial part of plants10
  • Live plants2

Preparations

  • Solvent extraction12

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
4-hydroxyacetophenoneAerial part of plantsSolvent extraction≤ 6.2 PercentHPLC with standard detection methodsResolve DOI
4-hydroxyacetophenoneAerial part of plantsSolvent extraction≥ 0.4 PercentHPLC with standard detection methodsResolve DOI
ErythroglaucinAerial part of plantsSolvent extraction0.2 Milligram/kilogramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
FabianineAerial part of plantsSolvent extraction0.043 Milligram/gramNuclear Magnetic Resonance (NMR)Resolve DOI
PhyscionAerial part of plantsSolvent extraction0.3 Milligram/kilogramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
ScopoletinAerial part of plantsSolvent extraction≤ 1.9 PercentHPLC with standard detection methodsResolve DOI
ScopoletinAerial part of plantsSolvent extraction≥ 0.8 PercentHPLC with standard detection methodsResolve DOI
ScopoletinAerial part of plantsSolvent extraction≤ 2400 Milligram/100 gramGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
ScopoletinAerial part of plantsSolvent extraction≥ 240 Milligram/100 gramGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
ScopoletinAerial part of plantsSolvent extraction0.089 Milligram/gramNuclear Magnetic Resonance (NMR)Resolve DOI
ScopoletinLive plantsSolvent extraction≤ 0.56 PercentHPLC-UVNo resolvable identifier
ScopoletinLive plantsSolvent extraction≥ 0.01 PercentHPLC-UVNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. KNAPP, JE., THEINER, M., SCHIFF, PL., FARNSWOR.NR. ANTHRAQUINONES AND OTHER CONSTITUENTS OF FABIANA-IMBRICATA. PHYTOCHEMISTRY, 1972, vol. 11, no. 10, p. 3091-&. DOI
  2. Schmeda-Hirschmann, G., Jordan, M., Gerth, A., Wilken, D., Hormazabal, E., Tapia, AA. Secondary metabolite content in Fabiana imbricata plants and in vitro cultures. ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2004, vol. 59, no. 1-2, p. 48-54.
  3. Quispe, Cristina., Viveros-Valdez, Ezequiel., Schmeda-Hirschmann, Guillermo. Phenolic Constituents of the Chilean Herbal Tea Fabiana imbricata R. et P.. PLANT FOODS FOR HUMAN NUTRITION, 2012, vol. 67, no. 3, p. 242-246. DOI
  4. RAZMILIC, I., SCHMEDAHIRSCHMANN, G., DUTRABEHRENS, M., REYES, S., LOPEZ, I., THEODULOZ, C. RUTIN AND SCOPOLETIN CONTENT AND MICROPROPAGATION OF FABIANA-IMBRICATA. PLANTA MEDICA, 1994, vol. 60, no. 2, p. 140-142. DOI
  5. SCHMEDAHIRSCHMANN, G., PAPASTERGIOU, F. SESQUITERPENES FROM FABIANA-IMBRICATA. PHYTOCHEMISTRY, 1994, vol. 36, no. 6, p. 1439-1442. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue